{
  "ticker": "IRX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969812",
  "id": "02969812",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250716",
  "time": "1227",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250716/pdf/06lvf7x8gf4f5k.pdf",
  "summary": "**Announcement Summary:**  \n\n- **Webinar Invitation**: Shareholder town hall webinar scheduled for **12pm AEST, 23 July 2025**.  \n- **Focus Areas**: Updates on clinical programs **IRX-211** (Breakthrough Cancer Pain) and **IRX-616a** (Panic Disorder).  \n- **Funding Facility**: Up to **$38.5m** secured for clinical development (no new capital raised disclosed).  \n\n**No material trading or capital markets information identified** (operational update only; no financial/structural changes).",
  "usage": {
    "prompt_tokens": 906,
    "completion_tokens": 119,
    "total_tokens": 1025,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-16T04:10:26.973959"
}